Full Breakdown
U.S. Health Secretary Robert F. Kennedy Jr. Faces Scrutiny Over David Geier's HHS Contract
4/22/2026, 10:37:13 PM
Key Details of the Hearing
During a recent Senate Finance Committee hearing, U.S. Health Secretary Robert F. Kennedy Jr. addressed inquiries regarding the employment contract of David Geier, a controversial figure known for his anti-vaccine activism. Kennedy confirmed his willingness to share Geier's contract with senators by the end of the week, marking a significant moment in the ongoing scrutiny of Geier's role within the Department of Health and Human Services (HHS). Geier is listed as a senior data analyst and is reportedly involved in a vaccine safety review of data from the Centers for Disease Control and Prevention (CDC).
Background on David Geier
David Geier has a history of promoting discredited theories linking vaccines to autism, a stance that contradicts established scientific consensus. His previous actions include being fined in Maryland for practicing medicine without a license and for prescribing unapproved treatments to children diagnosed with autism. His association with Kennedy raises concerns among public health advocates regarding the integrity of vaccine safety evaluations.
Official Statements & Responses
Kennedy stated that while he would share Geier's contract, he could not provide protocols governing Geier's work because they have not yet been established. He indicated that these protocols would be made available once Geier's review is completed. This response has drawn attention from lawmakers, particularly Senator Ben Ray Luján, who expressed the need for transparency regarding Geier's contributions to the HHS.
Criticism & Opposition
Critics of Kennedy's decision to employ Geier argue that it undermines public trust in vaccine safety initiatives. Public health experts have voiced concerns that Geier's involvement could lead to biased interpretations of data, potentially jeopardizing the credibility of the CDC's vaccine safety assessments. The lack of existing protocols for Geier's work has further fueled skepticism about the oversight of his activities within the HHS.
Conflicting Reports & Gaps
While Kennedy has committed to sharing Geier's contract, there is uncertainty surrounding the timeline for the completion of Geier's review and the establishment of the necessary protocols. Additionally, the extent of Geier's influence on vaccine safety evaluations remains unclear, with no detailed information currently available about his specific responsibilities or the methodologies he will employ.
Verbatim Quotes
This situation continues to develop, with potential implications for public health policy and vaccine safety oversight in the United States.
